vimarsana.com
  1. Home
  2. Live Updates
  3. Atsena Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ATSN-101 Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis (LCA1) : vimarsana.com

Atsena Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ATSN-101 Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis (LCA1)

Atsena Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for ATSN-101 Gene Therapy for GUCY2D-associated Leber Congenital Amaurosis (LCA1)

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

North Carolina ,United States ,Patrick Ritschel ,Sanford Boye ,Shannon Boye ,Tony Plohoros ,University Of Florida ,Foundation Fighting Blindness ,Carolina Research Triangle ,Drug Administration ,Regenerative Medicine Advanced Therapy ,Chief Executive Officer ,Jason Menzo ,Foundation Fighting ,Century Cures Act ,Research Triangle ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.